Clinical Trial Update: Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial at the University of Calgary is evaluating bacteriophage therapy for prosthetic joint infections of the hip caused by Staphylococcus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection
• Staphylococcus Lugdunensis Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: University of Calgary | Conditions: Prosthetic Joint Infections of Hip, Bacteriophage Therapy | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING